atai Launches Revixia Life Sciences to Develop Salvinorin A for a Variety of Mental Health Conditions Post published:August 12, 2021 Post category:Press Release
Awakn Life Sciences Begins Trading on the OTCQB(R) Venture Market Under the Symbol ‘AWKNF’ on August 12th Post published:August 12, 2021 Post category:Press Release
Wesana Health Commences Functional Animal Study for Treatment of Traumatic Brain Injury Post published:August 11, 2021 Post category:Press Release
COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021 Post published:August 11, 2021 Post category:Press Release
MYND Life Sciences Announces DTC Eligibility Post published:August 11, 2021 Post category:Press Release
MindMed Appoints Dr. Robert Dworkin to Scientific Advisory Board Post published:August 10, 2021 Post category:Press Release
Tryp Therapeutics Partners with Calvert Labs to Conduct Exploratory Studies for Proprietary Psilocybin Formulations Post published:August 10, 2021 Post category:Press Release
MINDCURE Welcomes Dr. Ken Weingardt, Digital Therapy Visionary, as a Senior Clinical Technology Advisor to its Psychedelic Digital Therapeutics Team Post published:August 10, 2021 Post category:Press Release
Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline Post published:August 10, 2021 Post category:Press Release
Clerkenwell Partners with Leading Preclinical CRO Transpharmation to Advance Psychedelic Clinical Trials in Europe Post published:August 9, 2021 Post category:Press Release